| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281357 | Clinical Gastroenterology and Hepatology | 2015 | 10 Pages |
Abstract
PCCE-2 is feasible, safe, and well tolerated for the assessment of mucosal CD activity in selected populations. Larger studies are needed to assess its operating characteristics further. European clinical trials database number: 2014-003854-15.
Keywords
TNFVASSES-CDICCCDEISCDAISimple Endoscopic Score for Crohn’s DiseaseCrohn’s diseaseCrohn’s disease endoscopic index of severityInflammatory bowel diseaseDiagnosticImagingCrohn’s Disease Activity Indexintraclass correlation coefficientconfidence intervaltumor necrosis factorvisual analogue scaleMonitoringGelsOptical colonoscopyUlcerative colitis
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Geert D'Haens, Mark Löwenberg, Mark A. Samaan, Denis Franchimont, Cyriel Ponsioen, Gijs R. van den Brink, Paul Fockens, Peter Bossuyt, Leila Amininejad, Gopalan Rajamannar, Elsemieke M. Lensink, Andre M. Van Gossum,